Company Monitoring Page for Ironwood-Pharmaceuticals

latest headlines for company on cafepharma

Ironwood spies new frontier for $1B GLP-2 analog in exploratory phase 2 rare disease trial
Fierce Biotech
Thu, 03/28/24 - 11:16 am
Tags:
Ironwood Pharmaceuticals, apraglutide, VectaBio, graft vs host disease
Pipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpoints
Clinical Trials Arena
Mon, 03/18/24 - 11:09 am
Tags:
Ironwood Pharmaceuticals, short bowel syndrome, clinical trials, apraglutide
FDA approves 1st pediatric drug for functional constipation
Beckers Hospital Review
Tue, 06/13/23 - 10:58 pm
Tags:
Ironwood Pharmaceuticals, FDA, Linzess, pediatric, constipation
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
Ironwood to buy VectivBio for $1.15 billion to boost digestive disorder drugs portfolio
Yahoo/Reuters
Mon, 05/22/23 - 10:27 am
Tags:
Ironwood Pharmaceuticals, VectivBio, M&A, digestive disorders
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Yahoo/Benzinga
Mon, 02/15/21 - 10:37 am
Tags:
earnings, FDA, G1 Therapeutics, trilaciclib, Zoetis, EXACT Sciences, Blueprint Medicines, Ironwood Pharmaceuticals
The doctor will Zoom you now: Pharma execs talk ins and outs of telehealth
Fierce Pharma
Fri, 10/30/20 - 10:45 am
Tags:
telehealth, telemedicine, Ironwood Pharmaceuticals, Evofem Biosciences, Linzess, Phexxi, pharma marketing
Ironwood puts GERD hopeful on the chopping block, along with 100 staffers after flop
Fierce Biotech
Tue, 09/29/20 - 12:30 pm
Tags:
Ironwood Pharmaceuticals, IW-3718, layoffs, GERD
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Wed, 06/19/19 - 09:49 am
Tags:
Ironwood Pharmaceuticals, Allergan, Linzess, clinical trials, IBS-C
Ironwood Pharma Spins off Cyclerion Therapeutics With 5 Orphan Disease Compounds
BioSpace
Tue, 04/2/19 - 12:02 pm
Tags:
Ironwood Pharmaceuticals, Cyclerion, spinoffs, orphan diseases
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Tags:
Massachusetts, Boston, Biogen, Tecfidera, Benepali, Shire, Takeda, Vyvanse, Vertex Pharmaceuticals, Orkambi, Kalydeco, Alexion, Soliris, Strensiq, Sanofi Genzyme, Lantus, Ironwood Pharmaceuticals, Linzess
Ironwood spinout Cyclerion planning $175M private placement
BioCentury
Tue, 02/26/19 - 11:52 pm
Tags:
Cyclerion, Ironwood Pharmaceuticals
Ironwood to cut 35 more jobs as company split nears
BioPharma Dive
Wed, 02/13/19 - 04:52 pm
Tags:
Ironwood Pharmaceuticals, layoffs, spinoffs, Cyclerion
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Pharmaceutical Business Review
Thu, 01/24/19 - 10:55 am
Tags:
Ironwood Pharmaceuticals, IW-6463, CNS disorders, clinical trials
Ironwood names AstraZeneca exec as CEO; shares up 8%
Seeking Alpha
Sat, 01/5/19 - 01:41 pm
Tags:
Ironwood Pharmaceuticals, AstraZeneca, Mark Mallon
Ironwood, Allergan set to resolve LINZESS patent litigation with Mylan
Pharmaceutical Business Review
Thu, 01/3/19 - 09:40 am
Tags:
Ironwood Pharmaceuticals, Mylan, patents, Linzess
Novartis May Beat Ironwood Pharmaceuticals to the Punch
Motley Fool
Tue, 10/30/18 - 11:17 pm
Tags:
Novartis, crizanlizumab, sickle cell disease, Ironwood Pharmaceuticals, IW-1701
Ironwood secures FDA fast track designation for heart drug praliciguat
Pharmaceutical Business Review
Fri, 09/14/18 - 09:44 am
Tags:
Ironwood Pharmaceuticals, FDA, praliciguat, heart failure
Tue, 08/21/18 - 09:38 am
Tags:
Astellas, Ironwood Pharmaceuticals, Linzess
Ironwood Initiates Ph III Study of Linaclotide in IBS-C
CP Wire
Mon, 07/16/18 - 09:08 am
Tags:
Ironwood Pharmaceuticals, Allergan, linaclotide, Linzess, IBS-C

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.